Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Assessment of Two Commercial Comprehensive Gene Panels for Personalized Cancer Treatment.

Autor: Ottestad AL; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), 7030 Trondheim, Norway.; Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, 7030 Trondheim, Norway., Huang M; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), 7030 Trondheim, Norway.; Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, 7030 Trondheim, Norway.; Department of Biosciences and Nutrition, Karolinska Institute, 17177 Stockholm, Sweden., Emdal EF; Department of Pathology, Clinic of Laboratory Medicine, St. Olavs Hospital, Trondheim University Hospital, 7030 Trondheim, Norway., Mjelle R; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), 7030 Trondheim, Norway.; Department of Pathology, Clinic of Laboratory Medicine, St. Olavs Hospital, Trondheim University Hospital, 7030 Trondheim, Norway., Skarpeteig V; Department of Pathology, Clinic of Laboratory Medicine, St. Olavs Hospital, Trondheim University Hospital, 7030 Trondheim, Norway., Dai HY; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), 7030 Trondheim, Norway.; Department of Pathology, Clinic of Laboratory Medicine, St. Olavs Hospital, Trondheim University Hospital, 7030 Trondheim, Norway.

Publikováno v: Journal of personalized medicine [J Pers Med] 2022 Dec 26; Vol. 13 (1). Date of Electronic Publication: 2022 Dec 26.